China's Sinopharm, Sinovac vaccines in final stages of evaluation: WHO

Download

00:28

China's Sinopharm, Sinovac COVID-19 vaccines are in the final stages of evaluation, said the World Health Organization (WHO).

The two Chinese vaccines, once approved, will be used under the WHO's COVAX program, which aims to ensure equitable access to vaccines for the developing world.

Open in CGTN APP for better experience

Search Trends